Information  X 
Enter a valid email address

Unicorn AIM VCT PLC (UAV)

  Print      Mail a friend       Annual reports

Thursday 26 March, 2020

Unicorn AIM VCT PLC

Publication of Suppl.Prospcts

RNS Number : 7079H
Unicorn AIM VCT PLC
26 March 2020
 

Unicorn AIM VCT PLC ("the Company")

LEI: 21380057QDV7D34E9870

Publication of Supplementary Prospectus

 

26 March 2020

 

 

The Company issued a prospectus dated 11 February 2020 (Prospectus) relating to an offer for subscription to raise up to £15 million, with an over-allotment facility to raise up to a further £10 million (Offer).

 

On 24 March 2020 the Company published an unaudited NAV per Share of 119.6p as at 23 March 2020 reflecting, as further explained in the announcement on 25 March 2020, valuation reductions generally across the investments in the portfolio as a result of the market volatility arising from the impact of the Coronavirus (Covid-19) pandemic affecting all businesses including those in which the Company invests (Updated NAV Announcement).

 

The Company announces that, as a result of the Updated NAV Announcement, it has published a supplementary prospectus to the Prospectus (Supplementary Prospectus).

 

A copy of the Supplementary Prospectus has been submitted to the Financial Conduct Authority and will shortly be available for inspection at the National Storage Mechanism, which is located at: www.morningstar.co.uk/uk/nsm

 

Copies of this Supplementary Prospectus, together with the Prospectus, will be available from the following website:

 

www.unicornaimvct.co.uk

 

For further information please contact:

 

Chris Hutchinson at Unicorn Asset Management Limited (the Company's investment manager)

on 020 7253 0889.

 

ISCA Administration Services Limited (the Company Secretary) on 01392 487056

(or [email protected] ).


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
PSPPPUGCWUPUGUQ

a d v e r t i s e m e n t